Quantcast
Home > Quotes > PRVB

Provention Bio, Inc. Common Stock (PRVB) Quote & Summary Data

PRVB 
$3.145
*  
0.005
0.16%
Get PRVB Alerts
*Delayed - data as of Apr. 18, 2019  -  Find a broker to begin trading PRVB now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
7
Today's High / Low
$ 3.35 / $ 3.01
Share Volume
84,128
50 Day Avg. Daily Volume
40,091
Previous Close
$ 3.15
52 Week High / Low
$ 8 / $ 1.52
Market Cap
117,502,112
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0

Intraday Chart

Shares Traded

Share Volume:
84,128
50 Day Avg. Daily Volume:
40,091

Trading Range

The current last sale of $3.145 is 106.91% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 3.35 $ 8
 Low: $ 3.01 $ 1.52

Company Description (as filed with the SEC)

We are a clinical stage biopharmaceutical company, focused on the development and commercialization of novel therapeutics and solutions aimed at intercepting and preventing immune-mediated diseases. Since our inception, we have devoted substantially all of our efforts to research and development, business planning, recruiting management and technical staff, acquiring operating assets, partnering and raising capital. Our business is subject to significant risks and uncertainties and we will be dependent on raising substantial additional capital before it becomes profitable and it may never achieve profitability. We have not generated any revenue to date and through December 31, 2018, we had an accumulated deficit of $35.8 million. We have financed our operations through a private offering of Series A Convertible Redeemable Preferred Stock in April 2017, and our initial public offering, or IPO, in July 2018.  ... More ...  



Risk Grade

Where does PRVB fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 3.18
Open Date:
Apr. 18, 2019
Close Price:
$ 3.19
Close Date:
Apr. 18, 2019


Consensus Recommendation

Analyst Info